The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHILLION PHARMACEUTICALS | COM | 00448Q201 | 2,382 | 241,600 | SH | SOLE | 241,600 | 0 | 0 | ||
ACTINIUM PHARMACEUTICALS INC | COM | 00507W107 | 222 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 5,022 | 160,242 | SH | SOLE | 160,242 | 0 | 0 | ||
AFFIMED THERAPEUTICS BV | COM | N01045108 | 394 | 62,500 | SH | SOLE | 62,500 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 356 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
APPLIED GENETIC TECHNOL CORP | COM | 03820J100 | 2,185 | 109,323 | SH | SOLE | 109,323 | 0 | 0 | ||
APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 121 | 22,289 | SH | SOLE | 22,289 | 0 | 0 | ||
ASCENDIS PHARMA A S SPONSORED | ADR ADDED | 04351P101 | 1,623 | 93,541 | SH | SOLE | 93,541 | 0 | 0 | ||
ATRICURE INC | COM | 04963C209 | 13,061 | 637,431 | SH | SOLE | 637,431 | 0 | 0 | ||
AUSPEX PHARMACEUTICALS INC | COM | 05211J102 | 12,083 | 120,500 | SH | SOLE | 120,500 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 1,505 | 166,656 | SH | SOLE | 166,656 | 0 | 0 | ||
BIOTELEMETRY INC | COM | 090672106 | 2,085 | 235,645 | SH | SOLE | 235,645 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 966 | 8,000 | SH | SOLE | 8,000 | 0 | 0 | ||
BOVIE MEDICAL CORP | COM | 10211F100 | 239 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CARDICA INC | COM | 14141R101 | 936 | 1,486,004 | SH | SOLE | 1,486,004 | 0 | 0 | ||
CAREDX INC | COM | 14167L103 | 687 | 123,883 | SH | SOLE | 123,883 | 0 | 0 | ||
CAS MEDICAL SYSTEMS INC | COM PAR $0.004 | 124769209 | 134 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CHECK CAP LTD | SHS ADDED | M2361E112 | 605 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
CHECK CAP LTD-CW20 | *W EXP 02/28/202 ADDED | M2361E120 | 55 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
CHEMBIO DIAGNOSTICS INC | COM NEW | 163572209 | 106 | 26,287 | SH | SOLE | 26,287 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 1,737 | 23,400 | SH | SOLE | 23,400 | 0 | 0 | ||
COGENTIX MEDICAL INC | COM | 19243A104 | 593 | 353,181 | SH | SOLE | 353,181 | 0 | 0 | ||
CURIS INC | COM | 231269101 | 720 | 299,800 | SH | SOLE | 299,800 | 0 | 0 | ||
CUTERA INC | COM | 232109108 | 303 | 23,490 | SH | SOLE | 23,490 | 0 | 0 | ||
CYNAPSUS THERAPEUTICS INC | COM | 23257Y156 | 521 | 543,927 | SH | SOLE | 543,927 | 0 | 0 | ||
CYNAPSUS THERAPEUTICS INC | COM | 23257Y701 | 687 | 717,200 | SH | SOLE | 717,200 | 0 | 0 | ||
CYTRX CORP | COM PAR $.001 | 232828509 | 1,014 | 300,813 | SH | SOLE | 300,813 | 0 | 0 | ||
DERMA SCIENCES INC | COM PAR $.01 | 249827502 | 3,167 | 373,918 | SH | SOLE | 373,918 | 0 | 0 | ||
DISCOVERY LABORATORIES INC | COM NEW | 254668403 | 5,748 | 4,829,874 | SH | SOLE | 4,829,874 | 0 | 0 | ||
ENCISION INC | COM | 29254Q104 | 829 | 1,062,500 | SH | SOLE | 1,062,500 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 376 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
ESSA PHARMA INC | COM | 29668H104 | 1,422 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
EXACTECH INC | COM | 30064E109 | 811 | 31,636 | SH | SOLE | 31,636 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 99 | 20,190 | SH | SOLE | 20,190 | 0 | 0 | ||
GALENA BIOPHARMA INC | COM | 363256108 | 348 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
GENVEC INC | COM NEW | 37246C307 | 295 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
GLOBEIMMUNE INC | COM | 37957B100 | 69 | 9,445 | SH | SOLE | 9,445 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 3,536 | 106,018 | SH | SOLE | 106,018 | 0 | 0 | ||
INSULET CORP | NOTE 2.000% 6/1 | 45784PAD3 | 2,419 | 2,407,000 | PRN | SOLE | 2,407,000 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 564 | 2,000 | SH | SOLE | 2,000 | 0 | 0 | ||
JOHNSON AND JOHNSON | COM | 478160104 | 946 | 9,400 | SH | SOLE | 9,400 | 0 | 0 | ||
KERYX BIOPHARMACEUTICALS | COM | 492515101 | 443 | 34,800 | SH | SOLE | 34,800 | 0 | 0 | ||
LPATH INC | COM NEW | 548910306 | 276 | 111,884 | SH | SOLE | 111,884 | 0 | 0 | ||
LUMENIS LTD | SHS CL B | M6778Q121 | 372 | 31,072 | SH | SOLE | 31,072 | 0 | 0 | ||
MASIMO CORPORATION | COM | 574795100 | 2,177 | 66,000 | SH | SOLE | 66,000 | 0 | 0 | ||
MINERVA NEUROSCIENCES INC | COM | 603380106 | 507 | 101,317 | SH | SOLE | 101,317 | 0 | 0 | ||
NANOSPHERE INC | COM | 63009F105 | 139 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
NEOTHETICS INC | COM | 64066G101 | 1,534 | 186,807 | SH | SOLE | 186,807 | 0 | 0 | ||
NOVADAQ TECHNOLOGIES INC | COM | 66987G102 | 1,654 | 101,841 | SH | SOLE | 101,841 | 0 | 0 | ||
NUVASIVE INC | NOTE 2.750% 7/0 | 670704AC9 | 935 | 760,000 | PRN | SOLE | 760,000 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 6,341 | 366,554 | SH | SOLE | 366,554 | 0 | 0 | ||
OPEXA THERAPEUTICS INC | COM NEW | 68372T202 | 0 | 500 | SH | SOLE | 500 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 1,768 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PHARMACYCLICS INC | COM | 716933106 | 18,333 | 71,628 | SH | SOLE | 71,628 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | COM | 74365A101 | 2,191 | 1,230,789 | SH | SOLE | 1,230,789 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | NOTE 4.500% 9/1 | 74365AAB7 | 3,060 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 3,962 | 1,109,740 | SH | SOLE | 1,109,740 | 0 | 0 | ||
RTI SURGICAL INC | COM | 74975N105 | 424 | 85,918 | SH | SOLE | 85,918 | 0 | 0 | ||
SPECTRANETICS CORP | COM | 84760C107 | 1,384 | 39,812 | SH | SOLE | 39,812 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 2,815 | 1,372,862 | SH | SOLE | 1,372,862 | 0 | 0 | ||
SYNERON MEDICAL LTD | ORD SHS | M87245102 | 1,126 | 90,947 | SH | SOLE | 90,947 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM | 875372104 | 963 | 76,340 | SH | SOLE | 76,340 | 0 | 0 | ||
TARGACEPT INC | COM | 87611R306 | 1,382 | 465,293 | SH | SOLE | 465,293 | 0 | 0 | ||
THRESHOLD PHARMACEUTICALS | COM NEW | 885807206 | 2,540 | 625,558 | SH | SOLE | 625,558 | 0 | 0 | ||
TONIX PHARMACEUTICALS HLDG C | COM NEW | 890260201 | 91 | 14,400 | SH | SOLE | 14,400 | 0 | 0 | ||
TRANSITION THERAPEUTICS INC | COM NEW | 893716209 | 180 | 26,410 | SH | SOLE | 26,410 | 0 | 0 | ||
UNIQURE B.V. | NV SHS | N90064101 | 730 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
VENAXIS INC | COM | 92262A107 | 305 | 658,000 | SH | SOLE | 658,000 | 0 | 0 | ||
XENOPORT INC | COM | 98411C100 | 828 | 116,259 | SH | SOLE | 116,259 | 0 | 0 | ||
ZOGENIX INC | COM | 98978L105 | 1,170 | 853,700 | SH | SOLE | 853,700 | 0 | 0 | ||
ZS PHARMA INC | COM | 98979G105 | 1,645 | 39,100 | SH | SOLE | 39,100 | 0 | 0 |